CBIO:Catalyst Biosciences Inc - Stock Price Quote and Dividend Data
LATEST CLOSE STOCK PRICE
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeReverse Split
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
52-Week Low/High Stock Price$3.43 - $10.00
Percent Held by Institutions63.26%
PE Ratio to Industry31%
Debt-Equity to Industry1.36%
Total Return Last 12 Months-58.87%
Total Return Last 3 Years-20.00%
Total Return Last 5 Years-74.61%
Latest Trade DateApr. 07, 2020
No Data available for Payment History.
Catalyst Biosciences is a clinical-stage biotechnology company focused on developing medicines to address hematology indications, including the treatment of hemophilia. Co. is focusing its product development efforts in the fields of hemostasis (the process that regulates bleeding). Co.'s principal product candidate is Factor VIIa (MarzAA), a Factor VIIa variant. MarzAA is being developed for the prophylactic treatment of individuals with hemophilia A and B with inhibitors. Co.'s second product candidate is Factor IX variants, a subcutaneously dosed Factor IX drug for the prophylactic treatment of individuals with hemophilia B.
SegmentPharmaceuticals & Biotechnology
Dividend AllStar™ Ranking
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Apr. 07, 2020CLOSE PRICE INCREASE: Catalyst Biosciences Inc (NASDAQ: CBIO) on 04-07-2020 increased close price > 10% from $3.76 to $4.33Read more...
Mar. 25, 2020CLOSE PRICE INCREASE: Catalyst Biosciences Inc (NASDAQ: CBIO) on 03-25-2020 increased close price > 10% from $3.90 to $4.42Read more...
Mar. 17, 2020CLOSE PRICE DECREASE: Catalyst Biosciences Inc (NASDAQ: CBIO) on 03-17-2020 decreased close price > 10% from $4.13 to $3.70Read more...
Apr. 08, 2020CLOSE PRICE DECREASE: Aeolus Pharmaceuticals Inc (OTCBB: AOLS) on 04-08-2020 decreased close price > 10% from $0.00 to $0.00Read more...
Apr. 08, 2020CLOSE PRICE INCREASE: Chembio Diagnostics Inc (NASDAQ: CEMI) on 04-08-2020 increased close price > 10% from $6.21 to $7.02Read more...
Apr. 08, 2020CLOSE PRICE INCREASE: Elite Pharmaceuticals Inc (OTCBB: ELTP) on 04-08-2020 increased close price > 10% from $0.08 to $0.09Read more...